The recent surge in funding into specialized pharmaceutical companies, particularly those focusing on novel therapies and difficult drug development programs, has fueled what some are calling "High Roller Pharma." https://myabceq603814.wssblogs.com/40070761/high-investor-pharma-a-hazardous-investment